References
- Caldwell G, Kellet H A, Gow S M, Beckett G J, Sweeting V M, Seth J, et al. A new strategy for thyroid function testing. Lancet 1985; i: 1117–19
- Klee G G, Hay I D. Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: Proposed criteria for analytic performance and clinical utility. J Clin Endocrinol Metab 1987; 64: 461–71
- Nicoloff J T, Spencer C A. The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990; 71: 553–8
- Hemmilä I A. Applications of fluorescence in immunoassays. Chemical analysis, J D Winefordner. Wiley, New York 1991; 117
- Ekins R. Immunoassay design and optimization. Principles and practice of immunoassay. 1st ed., C P Price, D J Newman. Stockton Press, New York 1991; 96–153
- Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307–10
- Taimela E, Tähtelä R, Koskinen P, Nuutila P, Forsström J, Taimela S, et al. Ability of two new thyrotropin (TSH) assays to separate hyperthyroid patients from euthyroid patients with low TSH. Clin Chem 1994; 40: 101–5
- Nuutila P, Irjala K, Viikari J, Prinssi V-P, Kaihola H-L. Comparative evaluation of serum thyroxine, free thyroxine and thyrotropin determinations in screening of thyroid function. Ann Clin Res 1988; 20: 158–63
- Mazzaferri E L. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553–9